Showing 5,661 - 5,680 results of 7,608 for search '"oncology"', query time: 0.09s Refine Results
  1. 5661
  2. 5662

    Optical and MRI Multimodal Tracing of Stem Cells In Vivo by Jia Yang, Min Yan, Zhong Wang, Cong Zhang, Miao Guan, Zhenglong Sun

    Published 2023-01-01
    “…Stem cell therapy has shown great clinical potential in oncology, injury, inflammation, and cardiovascular disease. …”
    Get full text
    Article
  3. 5663
  4. 5664

    Volatile Organic Metabolites as Potential Biomarkers for Genitourinary Cancers: Review of the Applications and Detection Methods by Kiana L. Holbrook, Wen-Yee Lee

    Published 2025-01-01
    “…The potential use of VOCs in detection, monitoring disease progression, and treatment responses in the field of genitourinary oncology is examined.…”
    Get full text
    Article
  5. 5665

    Evolution of uncontrolled proliferation and the angiogenic switch in cancer by John D. Nagy, Dieter Armbruster

    Published 2012-09-01
    “…The major goal of evolutionary oncology is to explain how malignant traits evolve to become cancer 'hallmarks.' …”
    Get full text
    Article
  6. 5666

    Emerging Prospects for Nanoparticle-Enabled Cancer Immunotherapy by Manal Ali Buabeid, El-Shaimaa A. Arafa, Ghulam Murtaza

    Published 2020-01-01
    “…The last part of this review deals with cancer immunotherapy using a combination of traditional interventional oncology approach and image-guided local immunotherapy against cancer. …”
    Get full text
    Article
  7. 5667
  8. 5668
  9. 5669

    The mycobiome in human cancer: analytical challenges, molecular mechanisms, and therapeutic implications by Ting Ding, Chang Liu, Zhengyu Li

    Published 2025-01-01
    “…The interaction between cancer cells, immune cells, and microbiota is defined as the immuno-oncology microbiome (IOM) axis. Fungal microbes (the mycobiome), although representing only ∼ 0.1-1% of the microbiome, are a critical immunologically active component of the tumor microbiome. …”
    Get full text
    Article
  10. 5670
  11. 5671
  12. 5672

    Targeting heparan sulfate proteoglycans as an effective strategy for inhibiting cancer cell migration and invasiveness compared to heparin by Lorenzo Depau, Jlenia Brunetti, Chiara Falciani, Elisabetta Mandarini, Marta Zanchi, Maria Francesca Paolocci, Marta Garfì, Alessandro Pini, Luisa Bracci

    Published 2025-01-01
    “…Despite a strong conceptual basis and promising preclinical results, clinical trials have failed to demonstrate any significant advantage of administering heparin to oncology patients. We exploited our anti-heparan sulfate branched peptide NT4 to test the opposite approach, namely, targeting HSPGs to interfere with their functions, instead of using heparin as a soluble competitor in human cell lines from pancreas adenocarcinoma, colon adenocarcinoma, rhabdomyosarcoma and two different breast cancers. …”
    Get full text
    Article
  13. 5673
  14. 5674
  15. 5675

    Case of Primary Breast and Ipsilateral Axillary T-Cell Lymphoma: a Rare Occurrence by Faryal Afridi, Garry D. Ruben, Eric Oristian

    Published 2020-01-01
    “…She was then referred to medical oncology for management. Conclusion. Although rare, lymphoproliferative disorders of the breast can be encountered during workup for suspicious breast lesions. …”
    Get full text
    Article
  16. 5676
  17. 5677
  18. 5678
  19. 5679
  20. 5680